淋巴瘤试验的放疗靶区命名:国家临床试验网络组的共识建议
针对依赖全身治疗后影像的淋巴瘤放疗靶区缺乏标准化命名的问题,国家临床试验网络组于2024年秋季召开论坛并建立标准化命名。该命名定义了累及部位放疗、残留部位放疗和PET引导放疗三类靶区,其中PET引导放疗又分为三种类型。
要点
- 累及部位放疗包括化疗前病变的完整头尾范围,仅考虑轴向解剖变化。
- 残留部位放疗仅针对化疗后CT解剖肿块。
- PET引导放疗仅针对PET阳性病变,分为PET引导累及部位放疗、PET引导残留部位放疗和PET引导残留PET放疗三种类型。
核心结论
- 国家临床试验网络组建立了淋巴瘤放疗靶区的标准化命名,包括累及部位放疗、残留部位放疗和PET引导放疗三类。
研究设计与样本
- 由美国国家临床试验网络组(NRG Oncology、儿童肿瘤组、SWOG癌症研究网络、肿瘤临床试验联盟、东部肿瘤协作组-美国放射学影像网络癌症研究组和加拿大癌症试验组)的放疗肿瘤学淋巴瘤领导者组成的论坛于2024年秋季召开并建立标准命名。
主要发现
- 累及部位放疗包括化疗前疾病的完整头尾范围,仅考虑轴向解剖变化。
- 残留部位放疗仅针对化疗后CT解剖肿块。
- PET引导放疗仅针对PET阳性病变,包括三种类型:PET引导累及部位放疗使用化疗前累及疾病部位中治疗后影像仍PET阳性的上下方面;PET引导残留部位放疗仅使用化疗后CT解剖残留肿块中包含PET阳性病变的部分,不排除完全代谢缓解的部位;PET引导残留PET放疗仅使用PET阳性病灶,不考虑周围相应的非PET阳性CT解剖疾病。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Contemporary lymphoma radiation target volumes that rely on post-systemic therapy imaging do not have standardised nomenclature. A forum of radiation oncology lymphoma leaders from the National Clinical Trials Network groups (NRG Oncology, Children's Oncology Group, SWOG Cancer Research Network, Alliance for Clinical Trials in Oncology, Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group, and the Canadian Cancer Trials Group) was convened and established standardised nomenclature for these volumes in the autumn of 2024. Involved-site radiotherapy includes the full cranial-caudal extent of prechemotherapy disease and takes into account axial anatomical changes only. Residual site radiotherapy targets only the postchemotherapy CT-anatomical mass. PET-directed radiotherapy exclusively targets PET-positive disease and includes three types: PET-directed involved site radiotherapy using the superior-inferior aspect of prechemotherapy involved disease sites that remain PET-avid on post-treatment imaging; PET-directed residual site radiotherapy using only the postchemotherapy CT-anatomical residual mass that contains the PET-avid lesion on post-treatment imaging, without excluding sites that had complete metabolic response; and PET-directed residual PET radiotherapy using only the PET-avid focus, irrespective of the corresponding adjacent non-PET-avid CT-anatomical disease surrounding it.
引用
- Saifi O, Pinnix CC, Ballas LK, et al. Radiation target nomenclature for lymphoma trials: consensus recommendations from the National Clinical Trials Network groups. Lancet Haematol. 2024. PMID: 39362223. doi:10.1016/S2352-3026(24)00276-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。